-
Lung Cancer Treatment Landscape: New Options and Ongoing Challenges
Drs. Upal Basu Roy, Amy Moore, and Dhru Deb discuss their recent publication in which they presented an analysis of the lung cancer drug pipeline. They talk about what it means for... -
Facebook Live: A Conversation with the EGFR Resisters Patient Group
Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, chats with Jill Feldman and Ivy Elkins, co-founders of the EGFR Resisters; and Drs. Christine Lovly, MD, PhD... -
Tips for Better Sleep
Sleep tips session with our sleep expert, Peggy Burhenn. -
New Options in Adjuvant Therapy for Early-Stage NSCLC
Historically, surgery has been the most effective treatment for patients with early-stage non-small cell lung cancer (NSCLC). While technological improvements, such as the... -
Studying Drug Resistance From a New Angle
The development of “targeted therapies” which block the function of mutant proteins within tumor cells has revolutionized the treatment landscape for many cancers, most of all lung... -
Highlights of the 2022 AACR meeting
The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in...
EGFR